Skip to main content
Premium Trial:

Request an Annual Quote

Sumitomo to Acquire Life Sciences VC Oxford Finance

NEW YORK, Jan. 30 (GenomeWeb News) - Oxford Finance, which has backed several genomics companies, is slated to be acquired by Sumitomo of Japan, the companies said yesterday.


Oxford, privately held and based in Alexandria, Va., has provided financing to several life sciences tools companies, including US Genomics, Structural Genomix, and Cellular Genomics. The company said its has a total of 50 active portfolio companies.


If the deal closes, Sumitomo America will acquire all of Oxford's assets for $51 million plus the assumption of certain liabilities related to its businesses, Oxford said.


Sumitomo said it believes the transaction will enable Oxford to triple its portfolio in the net three years and offer its clients and venture capitalists increased access to the Japanese life sciences community, as well as expand its client base and line of products.




The Scan

Highly Similar

Researchers have uncovered bat viruses that are highly similar to SARS-CoV-2, according to Nature News.

Gain of Oversight

According to the Wall Street Journal, the Biden Administration is considering greater oversight of gain-of-function research.

Lasker for mRNA Vaccine Work

The Scientist reports that researchers whose work enabled the development of mRNA-based vaccines are among this year's Lasker Award winners

PLOS Papers on Causal Variant Mapping, Ancient Salmonella, ALK Fusion Test for NSCLC

In PLOS this week: MsCAVIAR approach to map causal variants, analysis of ancient Salmonella, and more.